Igor Edouard Fisch
Gründer bei Selexis SA
Profil
Igor Edouard Fisch is the founder of Selexis SA, which was founded in 2001.
He holds the title of Director at Selexis SA. Currently, Dr. Fisch is a Member-Strategy Council at Venturelab AG.
In the past, he was a Director-Executive Board at Viroblock SA from 2010 to 2011 and a Director at Affitech A from 2011 to 2012.
Dr. Fisch obtained a doctorate degree from the University of Cambridge.
Aktive Positionen von Igor Edouard Fisch
| Unternehmen | Position | Beginn |
|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Gründer | 21.01.2010 |
Venturelab AG
 Venturelab AG Investment ManagersFinance Venturelab AG (Venturelab) is an independent venture capital firm headquartered in Schliren, Switzerland. The firm was founded by Beat Schillig and Jordi Monserrat in 2001. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Igor Edouard Fisch
| Unternehmen | Position | Ende |
|---|---|---|
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Direktor/Vorstandsmitglied | - |
Viroblock SA
 Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Direktor/Vorstandsmitglied | 28.07.2009 |
Ausbildung von Igor Edouard Fisch
| University of Cambridge | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Viroblock SA
Viroblock SA Miscellaneous Commercial ServicesCommercial Services Viroblock SA develops and commercializes antiviral products. Viroblock technology uses a novel mechanism of action to inactivate enveloped viruses, human and avian such As influenzas, SARS virus and the AIDS virus. The company was founded by Donald F. H. Wallach in 2005 and is headquartered in Irvine, CA. | Commercial Services |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Affitech A/S engages in the development of human antibody therapeutics. It focuses on human antibodies for cancer such as hematological and solid tumors; and serious inflammatory conditions including rheumatoid arthritis and severe asthma. The firm enters into partnerships and collaborations with biotechnology companies for antibody discovery and development. The company was founded by Søren Mouritsen and Henrik Irgang Elsner on October 1, 1990 and is headquartered in Copenhagen, Denmark. | Health Technology |
Venturelab AG
Venturelab AG Investment ManagersFinance Venturelab AG (Venturelab) is an independent venture capital firm headquartered in Schliren, Switzerland. The firm was founded by Beat Schillig and Jordi Monserrat in 2001. | Finance |
